• Aenova Expands Capacity for Fill & Finish of Vaccines and Biologics contractpharma
    May 08, 2021
    New €16M area for sterile production including vaccine fill and finish is being built at the Aenova site in Latina, Italy.
  • Kemwell Biopharma increases capacity for manufacturing of biologics expresspharma
    April 28, 2021
    The company has acquired an Ambr 250, added three single use bioreactors (SUBs) to support process scale-up, preclinical toxicology batch and early cGMP clinical trial supplies at 250L to 1000L scale in its current facility.
  • Biologics CDMO market to double in value by 2026, suggests report europeanpharmaceuticalreview
    April 16, 2021
    Research suggests the increasing R&D investment in and adoption of biologics will drive growth in the global biologics contract development and manufacturing organisation (CDMO) market.
  • Cytovance Biologics Offers Licensing for Plasmid DNA Manufacturing contractpharma
    March 10, 2021
    The Keystone Expression System pDNA platform is an end-to-end solution for manufacturing GMP pDNA at scale.
  • Wacker Strengthens Biologics Business contractpharma
    February 05, 2021
    ​The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
  • Almac Expands Global Biologics Testing Services contractpharma
    January 28, 2021
    ​Almac Sciences, a member of the Almac Group, has expanded its biologics testing laboratory with significant investment in mass spectrometry equipment.
  • Charles River Partners with JADE contractpharma
    January 15, 2021
    ​Charles River Laboratories International Inc. has entered into a strategic partnership with JADE Biomedical (JADE), a provider of end-to-end quality management services for the biopharmaceutical industry.
  • Cytiva delivers modular biologics factory to Lonza prnasia
    January 14, 2021
    Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global healthcare solutions provider Lonza, in Guangzhou Biopark, China.
  • Abzena Unveils New Biologics GMP Manufacturing Site contractpharma
    January 12, 2021
    ​Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has added a sixth global site that will augment cGMP manufacturing capacity for mammalian biologics.
  • CDMO Stelis Continues Expansion contractpharma
    December 02, 2020
    ​Contract development and manufacturing organization (CDMO), Stelis BioSource, a division of Stelis Biopharma Pvt. Ltd., has started the next phase of its continued investment program after having already invested well over $100 million into its ...
PharmaSources Customer Service